TY  - CONF

T1  - Complete data from the letrozole (L), exemestane (E), and anastrozole (A) pharmacodynamic (PD) 'LEAP' trial: direct comparison of safety parameters between aromatase inhibitors (Als) in healthy postmenopausal women.

JO  - BREAST CANCER RESEARCH AND TREATMENT

PY  - 2006/01/01

AU  - McCloskey E

AU  - Hannon R

AU  - Lakner G

AU  - Clack G

AU  - Miyamoto A

AU  - Finkelman R

AU  - Eastell R

ED  - 

VL  - 100

SP  - S111

EP  - S111

Y2  - 2025/04/30

ER  -